Would it surprise you to know that we bring innovation to the field of generic medicine? Or that our research and development group includes more than 3,300 scientists and regulatory experts who innovate worldwide every day?
It’s true. And it’s why we’ve challenged ourselves to reach higher and go farther for more than 50 years.
Today we design bioequivalent versions of brand name medicines, many of which are difficult-to-manufacture and difficult-to-formulate. We strive to create enhanced versions of medicines to differentiate our products from the pack. And we pursue innovations in oral solid dose medicines, transdermals, injectables, creams, ointments, antiretrovirals and nearly a dozen other critical areas.
Why? Because we believe every disease can have a treatment. We believe every epidemic should come to an end. Medical conditions great and small should be manageable.